CARR Biosystems, a provider of separation and bioprocessing technologies for the pharmaceutical and biotechnology industries, announces it has acquired Alfa Wassermann (AW), a leader in continuous flow ultracentrifugation and fluid handling solutions, from Turytes S.p.A.. For more than 60 years, AW has designed, manufactured and serviced continuous flow ultracentrifugation systems used to separate, purify and concentrate viruses, virus-like particles and viral vectors in the production of vaccines, gene therapies and other biologics.
Read the full article: CARR Biosystems Acquires Alfa Wassermann, Expanding Its Bioprocessing Portfolio //
Source: https://www.accessnewswire.com/newsroom/en/biotechnology/carr-biosystems-acquires-alfa-wassermann-expanding-its-bioprocessing-portfolio-1207247